Equifax CFO sells 4,500 shares in planned trade

Equifax executive John W. Gamble Jr., EVP, CFO & COO, reported an open-market sale of 4,500 shares of Equifax common stock.

Rhea-AI Filing Summary

Equifax executive John W. Gamble Jr., EVP, CFO & COO, reported an open-market sale of 4,500 shares of Equifax common stock. The transaction took place on February 23, 2026 at a price of $195.72 per share and was executed under a pre-arranged Rule 10b5-1 trading plan adopted on November 21, 2025.

After this sale, Gamble directly holds 58,921 shares of Equifax common stock. The filing notes that these holdings include dividend equivalent units tied to restricted stock units that were increased through dividends reinvested through the company’s last dividend payment date.

Insider Trade Summary

Net Seller: 4,500 shares

Net Sell 1 txn

Insider GAMBLE JOHN W JR

Role EVP, CFO & COO

Sold 4,500 shs ($881K)

Type	Security	Shares	Price	Value
Sale	Common Stock	4,500	$195.72	$881K

Holdings After Transaction: Common Stock — 58,921 shares (Direct)

Footnotes (2)

1. F1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/21/2025.
2. F2. Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Equifax (EFX) executive John W. Gamble Jr. report?

John W. Gamble Jr., Equifax’s EVP, CFO & COO, reported selling 4,500 shares of common stock. The sale occurred on February 23, 2026 at $195.72 per share in an open-market transaction executed under a pre-arranged Rule 10b5-1 trading plan.

At what price did Equifax (EFX) insider John W. Gamble Jr. sell his shares?

John W. Gamble Jr. sold 4,500 Equifax common shares at $195.72 per share. This was an open-market sale executed under a Rule 10b5-1 trading plan, which allows pre-scheduled trades regardless of later material nonpublic information.

How many Equifax (EFX) shares does John W. Gamble Jr. hold after this Form 4 sale?

Following the reported sale, John W. Gamble Jr. directly holds 58,921 shares of Equifax common stock. The reported balance includes dividend equivalent units linked to restricted stock units, reflecting dividends that were reinvested through the company’s most recent dividend payment date.

Was the Equifax (EFX) insider sale by John W. Gamble Jr. part of a 10b5-1 plan?

Yes. The filing states that the sales were executed under a Rule 10b5-1 trading plan adopted by John W. Gamble Jr. on November 21, 2025. Such plans preset trading instructions, helping separate trading activity from subsequent inside information.

What role does John W. Gamble Jr. hold at Equifax (EFX) in this Form 4 filing?

In this Form 4, John W. Gamble Jr. is identified as Equifax’s Executive Vice President, Chief Financial Officer, and Chief Operating Officer. His officer status means his transactions in Equifax securities must be reported promptly under insider reporting rules.

Does the Equifax (EFX) Form 4 mention dividend equivalent units for John W. Gamble Jr.?

Yes. The footnotes explain that the reported holdings include accrued dividend equivalent units. These arise when dividends are reinvested into corresponding restricted stock units, increasing the number of units tied to Equifax common stock over time.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/25/2026 - 04:41 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

GAMBLE JOHN W JR

(Last) (First) (Middle)

1550 PEACHTREE STREET, N.W.

(Street)

ATLANTA GA 30309

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
EQUIFAX INC [ EFX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, CFO & COO

3. Date of Earliest Transaction (Month/Day/Year)
02/23/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/23/2026		S(1)		4,500	D	$195.72	58,921(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/21/2025.

2. Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

	/s/Lisa Stockard as Attorney-in-Fact	02/25/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.